Pregnancy News and Research

Latest Pregnancy News and Research

New clinical trial to evaluate safety of tenofovir gel in breastfeeding, pregnant women

Determining whether a promising HIV prevention gel is safe for women to use while they are pregnant or breastfeeding is the aim of a new clinical trial being conducted by the National Institutes of Health-funded Microbicide Trials Network.

21 Jun 2011

Adequate midwifery could save 3.6 million lives, new report shows

Up to 3.6 million deaths could be avoided each year in 58 developing countries if midwifery services are upgraded by 2015, according to a major new report released here today by UNFPA, the United Nations Population Fund, and partners.

20 Jun 2011

Mother and baby cytomegalovirus screening important to prevent consequences

According to health experts, pregnant women and newborns should be screened for a virus that causes brain damage and deafness. The study that appeared in the latest issue of The Medical Journal of Australia yesterday says hundreds of cases of cytomegalovirus (CMV) are likely being missed each year in Australia because of a lack of screening, denying babies treatment for the condition.

19 Jun 2011

FDA approves NULOJIX

Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) approved NULOJIX, the first selective T-cell costimulation blocker indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant, in combination with basiliximab induction, mycophenolate mofetil (MMF), and corticosteroids.

18 Jun 2011

Watson Pharmaceuticals confirms SEASONIQUE patent challenge

Watson Pharmaceuticals, Inc., a leading integrated global pharmaceutical company, today confirmed that the United States District Court for the District of Nevada denied Duramed Pharmaceuticals, Inc.'s request for a preliminary injunction and request for a temporary restraining order preventing Watson's launch of generic SEASONIQUE and ethinyl estradiol.

18 Jun 2011

Study evaluates impact of medication adherence, comorbidity on workforce productivity

A new study suggests that while medication adherence is a critical element in reducing the impact of illness, employers should view it as just one of multiple components that are needed in strategic employee disease-management initiatives.

18 Jun 2011

Cervical ripening that instigates preterm birth is distinct from normal term labor

Cervical ripening that instigates preterm labor is distinct from what happens at the onset of normal term labor, researchers at UT Southwestern Medical Center have found.

18 Jun 2011

Paternal exposure during pregnancy may affect man's ability to father a child

According to the California Teratogen Information Service (CTIS) Pregnancy Health Information Line, more studies are needed to evaluate men and the potential effect of illnesses, medications and lifestyle habits on fertility and pregnancy. For couples suffering fertility problems, the issue is linked to the potential father approximately 50 percent of the time. In close to a quarter of these cases, a specific cause is unknown.

18 Jun 2011

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene International Sàrl announced that clinical data from a Phase II study, conducted by investigators from the MD Anderson Cancer Center in Houston, TX, evaluating the combination regimen of REVLIMID plus rituximab (R2) in untreated, advanced stage, indolent B-cell non-Hodgkin's lymphomas, were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

18 Jun 2011

Longer looks: Turning doctors' views of alternative therapies; a male birth control pill; teenagers and tanning beds

Medicine has long decried acupuncture, homeopathy, and the like as dangerous nonsense that preys on the gullible. Again and again, carefully controlled studies have shown alternative medicine to work no better than a placebo. But now many doctors admit that alternative medicine often seems to do a better job of making patients well, and at a much lower cost, than mainstream care — and they're trying to learn from it.

18 Jun 2011

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Celgene International Sarl today announced a collaboration to conduct an international randomized study to evaluate the therapeutic potential of the REVLIMID/rituximab combination regimen (R2) in patients with newly diagnosed follicular lymphoma.

17 Jun 2011

VIVUS Avanafil phase 3 trial on erectile dysfunction meets primary endpoints

VIVUS, Inc. today announced that the positive results from REVIVE-RP, a phase 3 clinical trial evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED),will be presented this afternoon at the 2011 Cancer Survivorship and Sexual Health Symposium in Washington D.C.

17 Jun 2011

Eating disorders and abuse may increase likelihood of pregnancy and postpartum depression

One in 10 women experience depression during pregnancy or shortly after giving birth. Although the problem has received increased attention in recent years, little is known about the causes or early-warning signs of pregnancy-related depression. In a study published in the June 2011 issue of Journal of Women's Health, researchers at the University of North Carolina at Chapel Hill School of Medicine offer new clues to help doctors identify at-risk patients and refer them to treatment early on.

17 Jun 2011

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Celgene International Sàrl announced that clinical data from two studies evaluating the use of REVLIMID® (lenalidomide) with standard R-CHOP chemotherapy in patients with untreated diffuse large B cell (DLBCL) or grade 3 follicular lymphoma were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

17 Jun 2011

Unprescribed methods to bring on labor may not be effective

More than half of the women in a recently published survey reported that near the end of their pregnancies, they took it upon themselves to try to induce labor, mostly by walking, having sex, eating spicy food or stimulating their nipples.

17 Jun 2011

Varicocele surgery may increase testosterone production

17 Jun 2011

Viewpoints: Medicare eligibility age; Medicare 'scares'; questions about Fla. Medicaid managed care

The bottom line is that we probably need to start raising Medicare's eligibility age incrementally, given today's life-expectancy realities. But it is not going to be the silver bullet that saves Medicare.

17 Jun 2011

Pregnant women with depression unlikely to receive consistent treatment

Pregnant women who screen positive for depression are unlikely to receive consistent treatment, researchers say. That may translate to women spending more time in the hospital before babies are even born.

17 Jun 2011

Roundup: Few states raise taxes to ease budgets; Ala. Gov. signs abortion law; Texas House advances bill to turn Medicaid, Medicare into block grants

As 2011 began, the budget situation in state capitals looked more dire than just about anybody could remember. ... With Medicaid, the states had their hands tied. The new federal health care law prohibits states from cutting eligibility or making it harder for people to apply for coverage. So states had to find other ways to control costs. Idaho reduced the amount paid to hospitals and doctors to treat Medicaid patients, an idea that some 30 governors proposed this year.

17 Jun 2011

Low testosterone linked to varicoceles

As many as 15 percent of men have varicoceles, masses of enlarged and dilated veins in the testicles. There is new evidence that varicoceles, long known to be a cause of male infertility, interfere with the production of testosterone -- a crucial hormone to maintaining men's health. There is good news too: Microsurgery can increase testosterone levels in these men. Results of new research by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are in a recent edition of BJU International.

16 Jun 2011

Pregnancy News and Research

Latest Pregnancy News and Research

New clinical trial to evaluate safety of tenofovir gel in breastfeeding, pregnant women

Adequate midwifery could save 3.6 million lives, new report shows

Mother and baby cytomegalovirus screening important to prevent consequences

FDA approves NULOJIX

Watson Pharmaceuticals confirms SEASONIQUE patent challenge

Study evaluates impact of medication adherence, comorbidity on workforce productivity

Cervical ripening that instigates preterm birth is distinct from normal term labor

Paternal exposure during pregnancy may affect man's ability to father a child

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Longer looks: Turning doctors' views of alternative therapies; a male birth control pill; teenagers and tanning beds

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

VIVUS Avanafil phase 3 trial on erectile dysfunction meets primary endpoints

Eating disorders and abuse may increase likelihood of pregnancy and postpartum depression

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Unprescribed methods to bring on labor may not be effective

Varicocele surgery may increase testosterone production

Viewpoints: Medicare eligibility age; Medicare 'scares'; questions about Fla. Medicaid managed care

Pregnant women with depression unlikely to receive consistent treatment

Roundup: Few states raise taxes to ease budgets; Ala. Gov. signs abortion law; Texas House advances bill to turn Medicaid, Medicare into block grants

Low testosterone linked to varicoceles

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pregnancy News and Research

Latest Pregnancy News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in